Speaker(s): Margaret Jarvis, MD, Geisinger
Moderator: Dominick Agosti, LCSW, Geisinger
Learning Objectives
At the conclusion of this session, the participant should be able to:
- Differentiate buprenorphine from other opiates.
- Detail how buprenorphine is used to treat OUD.
- Explain Geisinger’s buprenorphine model.
Session date:
10/12/2023 - 8:00am to 9:00am EDT
Location:
Virtual
United States
See map: Google Maps
Add to calendar:
- 0.00 AAPA Category I CME
- 1.00 ACPE
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation Credit

Facebook
X
LinkedIn
Forward